Wegovy Maker to Limit Starter-Dose Supplies in U.S. as Demand Surges

México Noticias Noticias

Wegovy Maker to Limit Starter-Dose Supplies in U.S. as Demand Surges
México Últimas Noticias,México Titulares
  • 📰 WSJ
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Starter doses of the obesity drug Wegovy will be temporarily held back in the U.S. to safeguard supplies, said drugmaker Novo Nordisk

An older Novo Nordisk drug, Ozempic—which has been around for more than half a decade as a treatment for Type 2 diabetes—was also prescribed for weight loss, leading toNovo Nordisk on Thursday reported surging demand for both drugs and said it expects capacity limitations at some manufacturing sites to result in “continued periodic supply constraints and related drug shortage notifications across a number of products and geographies.” The supply capacity is gradually being expanded, it said.

Overall sales rose 27% to 53.37 billion Danish krone, equivalent to $7.92 billion, versus the roughly 52.5 billion krone implied by recent company guidance. “Growth is driven by increasing demand for our GLP-1-based diabetes and obesity treatments, particularly in the U.S. where the prescription trend for Wegovy highlights the high unmet need for people living with obesity,” Chief Executive Lars Fruergaard Jørgensen said.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

WSJ /  🏆 98. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Investors see big Novo Nordisk stock boost if obesity drug shows heart benefitInvestors see big Novo Nordisk stock boost if obesity drug shows heart benefitPositive trial data showing Novo Nordisk’s obesity drug helps save and extend lives, not just lose weight, could propel Europe's best-performing stock even higher, according to 10 investors and industry analysts interviewed by Reuters.
Leer más »

Ozempic, Wegovy and all those crazy, vivid dreams: Is there a connection?Ozempic, Wegovy and all those crazy, vivid dreams: Is there a connection?Many people taking Ozempic for weight loss or Wegovy for diabetes management have reported vivid, intense dreams and nightmares as a side effect of the semaglutide medications.
Leer más »

Safety worries over copycat versions of Ozempic and Wegovy prompt state crackdownsSafety worries over copycat versions of Ozempic and Wegovy prompt state crackdownsA growing number of states are threatening to take legal action against pharmacies that make or dispense unauthorized versions of Ozempic and Wegovy.
Leer más »

Rockies’ German Marquez will undergo Tommy John surgeryRockies’ German Marquez will undergo Tommy John surgeryRockies right-hander German Marquez, the team’s opening-day starter, will undergo Tommy John surgery, ending his 2023 season.
Leer más »

Rockies’ German Marquez will undergo Tommy John surgeryRockies’ German Marquez will undergo Tommy John surgeryRockies right-hander German Marquez, the team’s opening-day starter, will undergo Tommy John surgery, ending his 2023 season.
Leer más »

Pokémon TCG Reveals Pokémon Card 151: Blastoise ExPokémon TCG Reveals Pokémon Card 151: Blastoise ExICYMI: You knew it was coming eventually. Water-type Kanto Starter evolution Blastoise gets its first Pokemon ex card of the Scarlet & Violet era in PokemonTCG: PokemonCard151.
Leer más »



Render Time: 2025-02-26 18:48:08